Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · IEX Real-Time Price · USD
1.400
-0.070 (-4.76%)
At close: Jul 19, 2024, 4:00 PM
1.390
-0.010 (-0.71%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Barinthus Biotherapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for BRNS stock have an average target of 5.50, with a low estimate of 3.00 and a high estimate of 8.00. The average target predicts an increase of 292.86% from the current stock price of 1.40.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 13, 2024.
Analyst Ratings
The average analyst rating for BRNS stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $7 → $3 | Buy | Maintains | $7 → $3 | +114.29% | Jun 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +471.43% | Jun 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +471.43% | May 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +471.43% | Apr 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +471.43% | Apr 19, 2024 |
Financial Forecast
Revenue This Year
1.02M
from 802.00K
Increased by 27.18%
Revenue Next Year
1.02M
from 1.02M
EPS This Year
-1.84
from -1.91
EPS Next Year
-1.87
from -1.84
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 5.3M | 5.3M | 5.3M |
| Avg | 1.0M | 1.0M | 1.8M |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 554.6% | 414.7% | 414.7% |
| Avg | 27.2% | - | 80.4% |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.66 | -1.27 | -1.17 |
| Avg | -1.84 | -1.87 | -1.84 |
| Low | -2.04 | -2.16 | -2.34 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.